Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengqi Jiang

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Oncology|March 1, 2019
ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathwayYanwei Xing, Shuo Ren, Lianjie Ai, et al.
International Journal of Oncology|April 23, 2020
Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathwayFengqi Jiang, Yaodong Chen, Shuo Ren, et al.
Disease Markers|September 1, 2022
The Landscape of Early Growth Response Family Members 1-4 in Hepatocellular Carcinoma: Their Biological Roles and Diagnostic UtilityJinlong Liang, Jingyi Wang, Jinshui Zeng, et al.
Oncology Reports|January 8, 2021
Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinomaFengqi Jiang, Shuo Ren, Yaodong Chen, et al.
The International Journal of Biochemistry & Cell Biology|June 7, 2020
Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathwayShuo Ren, Yanwei Xing, Chengbo Wang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Oncology|March 1, 2019
ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathwayYanwei Xing, Shuo Ren, Lianjie Ai, et al.
International Journal of Oncology|April 23, 2020
Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathwayFengqi Jiang, Yaodong Chen, Shuo Ren, et al.
Disease Markers|September 1, 2022
The Landscape of Early Growth Response Family Members 1-4 in Hepatocellular Carcinoma: Their Biological Roles and Diagnostic UtilityJinlong Liang, Jingyi Wang, Jinshui Zeng, et al.
Oncology Reports|January 8, 2021
Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinomaFengqi Jiang, Shuo Ren, Yaodong Chen, et al.
The International Journal of Biochemistry & Cell Biology|June 7, 2020
Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathwayShuo Ren, Yanwei Xing, Chengbo Wang, et al.
Pageof 3